Efficacy, Safety of an Investigational Dose of Semaglutide Injection in Adults With Type 2 Diabetes

by DailyBriefers
3 comments

Michael Radin, MD, executive director, Diabetes Cardio Renal Medical Director Team, Medical Affairs, Novo Nordisk, discusses the findings around the efficacy and safety of the 2 mg dose of semaglutide for the treatment of type 2 diabetes.

Pharmacy Times interviewed Michael Radin, MD, executive director, Diabetes Cardio Renal Medical Director Team, Medical Affairs, Novo Nordisk, on results from the SUSTAIN FORTE phase 3 clinical trial evaluating an investigational 2 mg dose of semaglutide (Ozempic; Novo Nordisk) injection in adults with type 2 diabetes.

During the discussion, Radin addresses the findings around the efficacy and safety of the 2 mg dose of semaglutide among this patient population.

You may also like

3 comments

psilocybin mushrooms buy online September 19, 2023 - 1:34 pm

577673 928284I recognize there is surely an excellent deal of spam on this weblog. Do you want aid cleansing them up? I may assist in between classes! 216453

Reply
https://www.dallasnews.com/marketplace/2023/09/29/phenq-reviews-legit-diet-pills-or-fat-burner-scam/ October 9, 2023 - 5:03 pm

128260 838526In case you are viewing come up with alter in most of the living, starting point usually L . a . Weight reduction cutting down on calories platform are a wide stair as part of your attaining that most agenda. weight loss 414279

Reply
แทงบอล lsm99 November 7, 2023 - 4:16 am

6224 160984if the buffalo in my head could speak german i would not know a god damm thing. What i do know is that the language of art is out of this world. 850911

Reply

Leave a Comment